Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Bridging the Divide Between Doctors, Data Scientists

May 26, 2016 9:29 am | News | Comments

While new medical discoveries and innovations are in the news every day, doctors struggle daily with using information and techniques available right now while carefully adopting new concepts and treatments.


Biden to Host National Cancer Research Summit in Washington

May 26, 2016 9:17 am | by Josh Lederman, Associated Press | News | Comments

Vice President Joe Biden will bring together scientists, oncologists, donors and patients for a national conference on cancer research in Washington, the White House said Tuesday.


EMA Accepts Submission for Rituximab Biosimilar

May 26, 2016 9:08 am | News | Comments

Sandoz is committed to increasing patient access to high-quality, life-enhancing biosimilars.


EU Lifts Suicide Warning on Pfizer's Smoking-Cessation Pill

May 26, 2016 9:08 am | by Linda A. Johnson, AP Medical Writer | News | Comments

Europe's main drug regulator has lifted a 7-year-old warning about possible suicidal risks from Chantix, Pfizer's smoking-cessation pill.


TB Drug May Also Target Visceral Leishmaniasis

May 25, 2016 3:00 pm | by University of Dundee | News | Comments

Visceral leishmaniasis is a disease which blights the developing world with 200,000 to 400,000 new cases and 48,000 deaths annually. 


New Vasculitis Drug Set to Address a Number of Major Unmet Needs

May 25, 2016 2:00 pm | by Alexandria Annis, Immunology Analyst, GlobalData | Articles | Comments

In terms of the potential competition CCX168 may face in the AAV market, GlobalData expects that the drug will hold an advantage over several competitors due to attractive pricing.


Antidepressants Prescribed For More Than Depression

May 25, 2016 1:01 pm | by Stephanie Guzowski, Editor | News | Comments

Physicians are prescribing antidepressants for many reasons that range beyond a depression diagnosis. So says a recent study published in the Journal of the American Medical Association.


Theranos Voids Two Years of Tests Amid Building Pressure

May 25, 2016 1:00 pm | by Seth Augenstein, Digital Reporter | Articles | Comments

The erroneous tests could have led to thousands of misdirected health-care decisions over those two years.


FDA Accepts Allergan's NDA Filing for Oxymetazoline HCI Cream

May 25, 2016 8:41 am | News | Comments

The drug is a topical prescription for treating persistent facial erythema.


Scientists Gain Better Look at How HIV Infects, Controls Host Cells

May 25, 2016 8:36 am | by Rockefeller University | News | Comments

Viruses attack cells and commandeer their machinery in a complex and carefully orchestrated invasion.


UCB Faces U.S. Patent Challenge for Epilepsy Drug

May 25, 2016 8:29 am | by Wout Vergauwen, Reuters | News | Comments

This is the latest round in a legal battle between the Belgian pharmaceutical company and generic rivals.


Harnessing Nature's Vast Array of Venoms for Drug Discovery

May 25, 2016 8:27 am | by Scripps Research Institute | News | Comments

There are lessons to be learned from venoms.


Silencing Cholera's Social Media

May 25, 2016 8:26 am | by PLOS | News | Comments

Understanding how this works has potential for therapeutic purposes.


New Valeant CEO Discusses Turnaround Plan at Investor Conference

May 25, 2016 8:24 am | by Ryan Bushey, Digital Editor | Articles | Comments

Joseph Papa shed light on the potential strategy for reducing the drug maker's debt load.


Combination Immunotherapy Set to Become Integral Element of Renal Cell Carcinoma Treatment

May 25, 2016 8:24 am | by Maxime Bourgognon, PharmD, Oncology and Hematology Analyst, GlobalData | Articles | Comments

Combination approaches have the potential to generate twice as many sales in the recurrent RCC market.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.